New investigational drug for endometrial cancer

Trial ID:
IRB-25-8667
Jo Marie Tran Janco, MD

Inclusion Criteria

Patients must:

  • Be female and 18 years or older
    Have confirmed diagnosis of endometrial carcinoma
    Have 1 or 2 prior lines of therapy

Exclusion Criteria

Patients must not:

  • Had uterine sarcomas
    Have active or prior documented autoimmune inflammatory disorders
    Have recurrence of endometrial carcinoma
    Be pregnant or breastfeeding

Additional Info

All treatments and physician visits during the study will take place at Prebys Cancer Center in Hillcrest. Study participation will last up to 12 months.

For more information search NCT07044336 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org